News
-
Center releases a new POSHAN and PMMVY plan hotline number
.
A change to the Pradhan Mantri Matru Vandana Yojana (PMMVY) and POSHAN toll-free helpline number was announced by the Ministry of Women and Child Development on Friday. People will find it simpler to remember and obtain support services with the new number. According to the Ministry, “the new helpline number 1515 will be live from…
-
The 1st indigenous antibiotic to effectively treat cancer and resistant respiratory illnesses
.
Dr. Jitendra Singh, the Union Minister of State (Independent Charge) for Science and Technology, announced that India had created “Nafithromycin,” its first indigenously discovered antibiotic that is effective against resistant respiratory infections and especially helpful for cancer patients and poorly managed diabetics. The minister claims the antibiotic is the first fully conceptualized, developed, and clinically…
-
The Postal Department starts a medication distribution program for ex-servicemen
.
The Ministry of Communications said on Friday that the Department of Posts (DoP) has started a special medication delivery service for former service members. Under the Ex-Servicemen Contributory Health Scheme (ECHS), the service, which was introduced in partnership with the Department of Ex-Servicemen (DESW), would make it easier to pick up, schedule, transmit, and deliver…
-
WHO has identified three tainted cough syrups in India
.
In addition to identifying three tainted syrups produced in India, including the notorious Coldrif cough syrup, the World Health Organization (WHO) has asked authorities elsewhere to notify the organization if any of these items are found in their own nations. This comes weeks after the ingestion of tainted cough syrup was implicated in the deaths…
-
Swasth Nari and Sashakt Nari organized 9 lakh health camps, screening 3.6 crore people
.
Union Health Minister JP Nadda stated on Monday that nine lakh health camps have been held nationwide under the “Swasth Nari, Sashakt Parivar Abhiyaan.” Over 3.6 crore individuals have been checked for non-communicable diseases including cancer, diabetes, and hypertension by the health camps, Nadda said during a media gathering in the nation’s capital. Swasth Nari,…
-
Zydus, Granules, Glenmark, and others are recalling medications in the US due to quality concerns
.
The US Food and Drug Administration (USFDA) has announced that a number of Indian pharmaceutical companies, including Sun Pharma, Zydus, Unichem, Granules India, and Glenmark, are recalling medications that are available in the US market. According to the regulator’s most recent Enforcement Report, the recalls are connected to production problems, contaminants, and labeling errors. 13,824…
-
Trump declares up to 100 percent tariffs on pharmaceutical imports
.
US President Donald Trump declared that, as of October 1, 2025, imports of branded and patented prescription medications would be subject to tariffs of up to 100%. Given how much the Indian pharmaceutical industry depends on trade with other nations, especially the US, the decision could have a negative impact. “We will be imposing a…
-
After GST rate cut, govt waives mandatory re-labelling of medicines
.
In a major relief for the pharma sector, the government has dismissed the mandatory rule for drug manufacturers to recall, or re-label medicines already released in the market before September 22, the Department of Pharmaceuticals said. This follows the latest revision in Goods and Services Tax (GST) rates early this month by the GST Council,…
-
Govt loosens regulations for establishing Jan Aushadhi Kendras in major cities
.
The Union government has loosened the guidelines for establishing Jan Aushadhi Kendras (JAKs) by eliminating the minimum distance limits in “million-plus cities” and metropolitan areas. The pharmacy company wants to offer consumers high-quality medications at reasonable costs, and the relaxation of distance limits will help expand its reach. The Pharmaceuticals & Medical Devices Bureau of…
-
India’s Biocon launches its first US manufacturing facility
.
Biocon, an Indian biopharmaceutical business, announced the launch of its first US production facility. Based in Cranbury, New Jersey, and run by Biocon’s wholly-owned subsidiary Biocon Generics, the US FDA-approved plant can produce up to 2 billion tablets of oral solid dosage drugs annually. In 2023, the business purchased the plant from Eywa Pharma and…

Alexa Liv
1.5M Followers
Check out our new font generatorand level up your social bios. Need more? Head over to Glyphy for all the fancy fonts and cool symbols you could ever imagine.
